{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T16:20:29Z","timestamp":1779294029870,"version":"3.51.4"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010909","name":"Excellent Young Scientists Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010909","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82003213"],"award-info":[{"award-number":["82003213"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.bbrc.2025.152305","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T07:55:10Z","timestamp":1752566110000},"page":"152305","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["EPB41L3 as a prognostic biomarker suppressing cellular malignancy and correlating with the immune microenvironment in glioma"],"prefix":"10.1016","volume":"778","author":[{"given":"Xiang","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunpeng","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changqian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yangfeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lilin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duanyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengkhun","family":"Nov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiqiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2025.152305_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2020.02.002","article-title":"Immunotherapy for glioma: current management and future application","volume":"476","author":"Xu","year":"2020","journal-title":"Cancer Lett."},{"issue":"8","key":"10.1016\/j.bbrc.2025.152305_bib2","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of tumors of the central nervous system: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro Oncol."},{"issue":"4","key":"10.1016\/j.bbrc.2025.152305_bib3","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41582-022-00621-0","article-title":"Advances in local therapy for glioblastoma - taking the fight to the tumour","volume":"18","author":"van Solinge","year":"2022","journal-title":"Nat. Rev. Neurol."},{"issue":"1","key":"10.1016\/j.bbrc.2025.152305_bib4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/neuonc\/nov164","article-title":"Strategies to improve delivery of anticancer drugs across the blood-brain barrier to treat glioblastoma","volume":"18","author":"Oberoi","year":"2016","journal-title":"Neuro Oncol."},{"issue":"7","key":"10.1016\/j.bbrc.2025.152305_bib5","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1093\/neuonc\/noac033","article-title":"Ferroptosis, as the most enriched programmed cell death process in glioma, induces immunosuppression and immunotherapy resistance","volume":"24","author":"Liu","year":"2022","journal-title":"Neuro Oncol."},{"issue":"4","key":"10.1016\/j.bbrc.2025.152305_bib6","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.ccell.2023.03.004","article-title":"Neutralizing IL-8 potentiates immune checkpoint blockade efficacy for glioma","volume":"41","author":"Liu","year":"2023","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.bbrc.2025.152305_bib7","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s13045-021-01191-2","article-title":"Toll-like receptors and toll-like receptor-targeted immunotherapy against glioma","volume":"14","author":"Xun","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bbrc.2025.152305_bib8","article-title":"Integrative analysis of Neuregulin family members-related tumor microenvironment for predicting the prognosis in gliomas","volume":"12","author":"Zhao","year":"2021","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.bbrc.2025.152305_bib9","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1093\/neuonc\/nox182","article-title":"Trivalent CAR T cells overcome interpatient antigenic variability in glioblastoma","volume":"20","author":"Bielamowicz","year":"2018","journal-title":"Neuro Oncol."},{"issue":"1","key":"10.1016\/j.bbrc.2025.152305_bib10","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11060-011-0793-0","article-title":"Recent advances in the molecular understanding of glioblastoma","volume":"108","author":"Bleeker","year":"2012","journal-title":"J. Neuro Oncol."},{"issue":"4","key":"10.1016\/j.bbrc.2025.152305_bib11","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s11912-017-0585-6","article-title":"The effect of molecular diagnostics on the treatment of glioma","volume":"19","author":"Bush","year":"2017","journal-title":"Curr. Oncol. Rep."},{"issue":"6","key":"10.1016\/j.bbrc.2025.152305_bib12","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health organization classification of tumors of the central nervous system: a summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol."},{"issue":"4","key":"10.1016\/j.bbrc.2025.152305_bib13","first-page":"299","article-title":"Management of glioblastoma: state of the art and future directions","volume":"70","author":"Tan","year":"2020","journal-title":"CA Cancer J. Clin."},{"issue":"4","key":"10.1016\/j.bbrc.2025.152305_bib14","doi-asserted-by":"crossref","DOI":"10.1172\/JCI139542","article-title":"Inhibition of 2-hydroxyglutarate elicits metabolic reprogramming and mutant IDH1 glioma immunity in mice","volume":"131","author":"Kadiyala","year":"2021","journal-title":"J. Clin. Investig."},{"issue":"5","key":"10.1016\/j.bbrc.2025.152305_bib15","first-page":"1443","article-title":"EPB41L3 is a potential tumor suppressor gene and prognostic indicator in esophageal squamous cell carcinoma","volume":"52","author":"Zeng","year":"2018","journal-title":"Int. J. Oncol."},{"issue":"24","key":"10.1016\/j.bbrc.2025.152305_bib16","doi-asserted-by":"crossref","first-page":"4815","DOI":"10.1007\/s00018-014-1707-z","article-title":"Tumor suppressor role of protein 4.1B\/DAL-1","volume":"71","author":"Wang","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbrc.2025.152305_bib17","article-title":"Aberrant expression of the candidate tumor suppressor gene DAL-1 due to hypermethylation in gastric cancer","volume":"6","author":"Wang","year":"2016","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.bbrc.2025.152305_bib18","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/cbf.3170","article-title":"Epb41l3 suppresses esophageal squamous cell carcinoma invasion and inhibits MMP2 and MMP9 expression","volume":"34","author":"Zeng","year":"2016","journal-title":"Cell Biochem. Funct."},{"issue":"6","key":"10.1016\/j.bbrc.2025.152305_bib19","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00418-004-0716-7","article-title":"Immunolocalization of protein 4.1B\/DAL-1 during neoplastic transformation of mouse and human intestinal epithelium","volume":"122","author":"Ohno","year":"2004","journal-title":"Histochem. Cell Biol."},{"issue":"8","key":"10.1016\/j.bbrc.2025.152305_bib20","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1158\/1078-0432.CCR-04-2206","article-title":"Promoter methylation of DAL-1\/4.1B predicts poor prognosis in non-small cell lung cancer","volume":"11","author":"Kikuchi","year":"2005","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.bbrc.2025.152305_bib21","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/modpathol.3880558","article-title":"Differential involvement of protein 4.1 family members DAL-1 and NF2 in intracranial and intraspinal ependymomas","volume":"15","author":"Singh","year":"2002","journal-title":"Mod. Pathol."},{"issue":"7","key":"10.1016\/j.bbrc.2025.152305_bib22","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/modpathol.3800390","article-title":"Alterations of protein 4.1 family members in ependymomas: a study of 84 cases","volume":"18","author":"Rajaram","year":"2005","journal-title":"Mod. Pathol."},{"issue":"4","key":"10.1016\/j.bbrc.2025.152305_bib23","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/nbt.3772","article-title":"Toil enables reproducible, open source, big biomedical data analyses","volume":"35","author":"Vivian","year":"2017","journal-title":"Nat. Biotechnol."},{"issue":"1","key":"10.1016\/j.bbrc.2025.152305_bib24","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1186\/s13046-018-1002-1","article-title":"Classification of triple-negative breast cancers based on Immunogenomic profiling","volume":"37","author":"He","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.bbrc.2025.152305_bib25","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.immuni.2013.10.003","article-title":"Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer","volume":"39","author":"Bindea","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.bbrc.2025.152305_bib26","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinf."},{"issue":"3","key":"10.1016\/j.bbrc.2025.152305_bib27","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/gcc.20034","article-title":"Allele-specific loss of heterozygosity at the DAL-1\/4.1B (EPB41L3) tumor-suppressor gene locus in the absence of mutation","volume":"40","author":"Kittiniyom","year":"2004","journal-title":"Genes Chromosomes Cancer"},{"issue":"31","key":"10.1016\/j.bbrc.2025.152305_bib28","doi-asserted-by":"crossref","first-page":"12784","DOI":"10.1073\/pnas.0705499104","article-title":"Protein 4.1B suppresses prostate cancer progression and metastasis","volume":"104","author":"Wong","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.bbrc.2025.152305_bib29","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.3892\/or.2017.6000","article-title":"DAL-1 attenuates epithelial to mesenchymal transition and metastasis by suppressing HSPA5 expression in non-small cell lung cancer","volume":"38","author":"Qiu","year":"2017","journal-title":"Oncol. Rep."},{"issue":"38","key":"10.1016\/j.bbrc.2025.152305_bib30","doi-asserted-by":"crossref","first-page":"63724","DOI":"10.18632\/oncotarget.18892","article-title":"LINC00052 upregulates EPB41L3 to inhibit migration and invasion of hepatocellular carcinoma by binding miR-452-5p","volume":"8","author":"Zhu","year":"2017","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.bbrc.2025.152305_bib31","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1007\/s12253-019-00787-x","article-title":"Mutation and expression of a candidate tumor suppressor gene EPB41L3 in gastric and colorectal cancers","volume":"26","author":"Son","year":"2020","journal-title":"Pathol. Oncol. Res."},{"issue":"4","key":"10.1016\/j.bbrc.2025.152305_bib32","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7150\/ijms.27401","article-title":"Protein 4.1B suppresses tumor metastasis by regulating epithelial-mesenchymal transition progression in melanoma cells","volume":"16","author":"Wang","year":"2019","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.bbrc.2025.152305_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110193","article-title":"Tumor treating fields for high-grade gliomas","volume":"127","author":"Luo","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.bbrc.2025.152305_bib34","first-page":"283","article-title":"Over-expression of EPB41L3 promotes apoptosis of human cervical carcinoma ce","volume":"69","author":"Tuerxun","year":"2022"},{"key":"10.1016\/j.bbrc.2025.152305_bib35","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/8092751","article-title":"HDAC10 inhibits cervical cancer progression through downregulating the HDAC10-microRNA-223-epb41l3 Axis","volume":"2022","author":"Gu","year":"2022","journal-title":"J. Oncol."},{"issue":"1","key":"10.1016\/j.bbrc.2025.152305_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2019.152725","article-title":"miR-452 promotes the development of gastric cancer via targeting EPB41L3","volume":"216","author":"He","year":"2020","journal-title":"Pathol. Res. Pract."},{"issue":"2","key":"10.1016\/j.bbrc.2025.152305_bib37","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.18632\/aging.202158","article-title":"Erythrocyte membrane protein band 4.1-like 3 inhibits osteosarcoma cell invasion through regulation of Snai1-induced epithelial-to-mesenchymal transition","volume":"13","author":"Yuan","year":"2020","journal-title":"Aging (Albany NY)"},{"issue":"6","key":"10.1016\/j.bbrc.2025.152305_bib38","doi-asserted-by":"crossref","first-page":"584","DOI":"10.4103\/ijmr.IJMR_620_18","article-title":"Promoter-associated DNA methylation & expression profiling of genes (FLT 3, EPB41L3 & SFN) in patients with oral squamous cell carcinoma in the Khasi & Jaintia population of Meghalaya, India","volume":"150","author":"Khongsti","year":"2019","journal-title":"Indian J. Med. Res."},{"issue":"1","key":"10.1016\/j.bbrc.2025.152305_bib39","doi-asserted-by":"crossref","first-page":"368","DOI":"10.18632\/oncotarget.2745","article-title":"EPB41L3, TSP-1 and RASSF2 as new clinically relevant prognostic biomarkers in diffuse gliomas","volume":"6","author":"Perez-Janices","year":"2015","journal-title":"Oncotarget"},{"issue":"5897","key":"10.1016\/j.bbrc.2025.152305_bib40","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1126\/science.1164382","article-title":"An integrated genomic analysis of human glioblastoma multiforme","volume":"321","author":"Parsons","year":"2008","journal-title":"Science"},{"issue":"26","key":"10.1016\/j.bbrc.2025.152305_bib41","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1407279","article-title":"Glioma groups based on 1p\/19q, IDH, and TERT promoter mutations in tumors","volume":"372","author":"Eckel-Passow","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.bbrc.2025.152305_bib42","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1056\/NEJMoa043331","article-title":"MGMT gene silencing and benefit from temozolomide in glioblastoma","volume":"352","author":"Hegi","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"D1","key":"10.1016\/j.bbrc.2025.152305_bib43","doi-asserted-by":"crossref","first-page":"D607","DOI":"10.1093\/nar\/gky1131","article-title":"STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets","volume":"47","author":"Szklarczyk","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.bbrc.2025.152305_bib44","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.neuron.2020.10.012","article-title":"Role of aberrant spontaneous neurotransmission in SNAP25-associated encephalopathies","volume":"109","author":"Alten","year":"2021","journal-title":"Neuron"},{"issue":"7","key":"10.1016\/j.bbrc.2025.152305_bib45","doi-asserted-by":"crossref","first-page":"3819","DOI":"10.1073\/pnas.1920403117","article-title":"Synaptotagmin 1 oligomers clamp and regulate different modes of neurotransmitter release","volume":"117","author":"Tagliatti","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.bbrc.2025.152305_bib46","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/jnc.14986","article-title":"Synaptotagmin-7 enhances calcium-sensing of chromaffin cell granules and slows discharge of granule cargos","volume":"154","author":"Bendahmane","year":"2020","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.bbrc.2025.152305_bib47","doi-asserted-by":"crossref","first-page":"4076","DOI":"10.1038\/s41467-019-12015-w","article-title":"Synaptotagmin 1 clamps synaptic vesicle fusion in mammalian neurons independent of complexin","volume":"10","author":"Courtney","year":"2019","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.bbrc.2025.152305_bib48","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a020610","article-title":"Cell of origin for malignant gliomas and its implication in therapeutic development","volume":"7","author":"Zong","year":"2015","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.bbrc.2025.152305_bib49","article-title":"Challenges in the treatment of glioblastoma by chimeric antigen receptor T-cell immunotherapy and possible solutions","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.bbrc.2025.152305_bib50","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1525243","article-title":"Effect of combined anti-PD-1 and temozolomide therapy in glioblastoma","volume":"8","author":"Park","year":"2019","journal-title":"OncoImmunology"},{"issue":"1","key":"10.1016\/j.bbrc.2025.152305_bib51","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1186\/s13046-020-01778-6","article-title":"Clinical implication of cellular vaccine in glioma: current advances and future prospects","volume":"39","author":"Yan","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"26","key":"10.1016\/j.bbrc.2025.152305_bib52","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1056\/NEJMoa2202028","article-title":"Oncolytic DNX-2401 virus for pediatric diffuse intrinsic pontine glioma","volume":"386","author":"Jaime G\u00e1llego P\u00e9rez-Larraya","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.bbrc.2025.152305_bib53","doi-asserted-by":"crossref","first-page":"819","DOI":"10.18632\/oncotarget.13661","article-title":"M2-like tumor-associated macrophages drive vasculogenic mimicry through amplification of IL-6 expression in glioma cells","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.bbrc.2025.152305_bib54","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/imr.12860","article-title":"T follicular helper cells in germinal center B cell selection and lymphomagenesis","volume":"296","author":"Mintz","year":"2020","journal-title":"Immunol. Rev."},{"issue":"12","key":"10.1016\/j.bbrc.2025.152305_bib55","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.it.2017.10.003","article-title":"PD-1(hi)CXCR5(-)CD4(+) T(FH) cells play defense in cancer and offense in arthritis","volume":"38","author":"Gu-Trantien","year":"2017","journal-title":"Trends Immunol."},{"issue":"4","key":"10.1016\/j.bbrc.2025.152305_bib56","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.trecan.2022.12.007","article-title":"T follicular helper cells in cancer","volume":"9","author":"Guti\u00e9rrez-Melo","year":"2023","journal-title":"Trends Cancer"},{"issue":"1","key":"10.1016\/j.bbrc.2025.152305_bib57","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.immuni.2019.12.018","article-title":"Tumor immunology and tumor evolution: intertwined histories","volume":"52","author":"Galon","year":"2020","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.bbrc.2025.152305_bib58","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ccell.2017.02.009","article-title":"The microenvironmental landscape of brain tumors","volume":"31","author":"Quail","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbrc.2025.152305_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175097","article-title":"Role of TNFSF9 bidirectional signal transduction in antitumor immunotherapy","volume":"928","author":"Wu","year":"2022","journal-title":"Eur. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.bbrc.2025.152305_bib60","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1158\/1541-7786.MCR-10-0529","article-title":"miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3","volume":"9","author":"Li","year":"2011","journal-title":"Mol. Cancer Res."},{"issue":"7","key":"10.1016\/j.bbrc.2025.152305_bib61","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1593\/neo.10340","article-title":"Microcell-mediated chromosome transfer identifies EPB41L3 as a functional suppressor of epithelial ovarian cancers","volume":"12","author":"Dafou","year":"2010","journal-title":"Neoplasia"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25010204?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25010204?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T10:46:27Z","timestamp":1777459587000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X25010204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":61,"alternative-id":["S0006291X25010204"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.152305","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"EPB41L3 as a prognostic biomarker suppressing cellular malignancy and correlating with the immune microenvironment in glioma","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.152305","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"152305"}}